The Darlington and Northallerton Long Term Asthma Study: Pulmonary function

BMC Pulmonary Medicine

Volumn 5, Issue , 2005, Pages

  Connolly, C Kevin ^a   Prescott, Robin J ^b  

^a DARLINGTON MEMORIAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG;

ADULT; AGE; ARTICLE; ASTHMA; CALCULATION; CLINICAL OBSERVATION; CLINICAL PROTOCOL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LINEAR REGRESSION ANALYSIS; LONG TERM CARE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; AGED; DISEASE COURSE; LUNG; LUNG FUNCTION TEST; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; ASTHMA; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS;

EID: 26844579304     PISSN: 14712466     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-5-2     Document Type: Article

References (27)

1. Ulrik CS, Backer V, Dirksen A: A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992, 47:14-18.
2. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G: A 15-year follow-up study of ventilatory function in adults with asthma. New England Journal of Medicine 1998, 339:1194-200.
3. Woolcock A: Corticosteroid-resistant asthma: Definitions. Am Rev Respir Dis 1996, 154(Suppl 2 pt2):S45-48.
4. Wilson JW, Bamford TL: Assessing the evidence for remodelling of the airway in asthma. Pulmonary Pharmacology & Therapeutics. 2001, 14:229-47.
5. Jeffrey PK: Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991, 143:1152-1158.
6. Connolly CK, Prescott RJ, Alcock SM, Gatnash AA: Actual over best function as an outcome measure for asthma. Respir Med 1994, 88:453-459.
7. British Thoracic Society, Scottish Intercollegiate Guidelines Network: British Guideline on the Management of Asthma. Thorax 2003, 58(Suppl 1):.
8. Connolly CK, Alcock SM, Prescott RJ: Management and control of asthma as assessed by actual/best function and corticosteroid usage between 1980 and 1993/4. Eur Resp J 1998, 12:859-864.
9. Connolly CK, Chan NS, Prescott RJ: The relationship between age and duration of asthma and the presence of persistent obstruction in asthma. Post Grad Med 1988, 64:422-425.
10. Connolly CK, Chan NS, Prescott RJ: The influence of social factors on control of asthma. Post Grad Med J 1989, 65:282-285.
11. Connolly CK, Alcock SM, Prescott RJ: Mortality in Asthmatics over 15 years; a dynamic cohort study from 1983 - 1998. Eur Respir J 2002, 19:593-598.
12. Cotes JE, Lung Function: 4th edition. Oxford, Blackwell Scientific Publications; 1979.
13. Orie NG, Sluiter HJ, de Vries K, Tameling GJ, Witkop J: The host factor in bronchitis. In Bronchitis: an international symposium, 27-29 April 1960 University of Gronigen. Assen: Royal van Gorcum; 1961:43-59.
14. Stockley RA, O'Brien C, Pye A, Hill SL: Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000, 117:1638-45.
15. Connolly CK, Murthy NK, Alcock SM, Prescott RJ: Sputum and pulmonary function in asthma. Chest 1997, 112:994-9.
16. The COPD Guidelines Group of the Standards of Care Committee of the BTS: BTS Guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997, 52(supp 5):.
17. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Eur Respir J 1993, 6(suppl 16):5-40.
18. Vollmer WM, Johnson LR, McCamant LE, Buist AS: Longitudinal versus cross-sectional estimation of lung function decline - further insights. Statistics in Med 1988, 7:685-96.
19. Weiss ST, Ware JE, Schouten J, Rucken B, eds: American Thoracic Society-European Respiratory Society Longitudinal Data Workshop. Am Rev Respir Dis 1996, 154(6 part 2 Suppl):.
20. Ware JH, Dockery DW, Louis TA, Xu X, Ferris BG Jr, Speizer FE: Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults. Am J Epidemiol 1990, 132:685-700.
21. Nakadate T: Longitudinal observation of pulmonary function decline in male Japanese workers: design, baseline results, and methodological considerations of handling pulmonary function data. Industrial Health 1998, 36:305-11.
22. Baltopoulos G, Fildisis G, Karatzas S, Georgiakodis F, Myrianthefs P: Reference values and prediction equations for FVC and FEV(1) in the Greek elderly. Lung 2000, 17:201-12.
23. Robbins DR, Enright PL, Sherrill DL: Lung function development in young adults: is there a plateau phase? Eur Respir J 1995, 8:768-72.
24. Burge PS: EUROSCOP, ISOLDE and the Copenhagen city lung study. Thorax 1999, 54:287-288.
25. Martin AJ, Landau LI, Phelan PD: Lung function in young adults who had asthma in childhood. Am Review of Respir Dis 1980, 122:609-16.
26. Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, Sears MR: Risk factors for airway remodelling in asthma manifested by a low post bronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir & Critical Care Med 2002, 165:1480-1488.
27. Fletcher CM, Peto R, Tinker CM, Spizer FE: The Natural History of Chronic Bronchitis and Emphysema. Oxford, Oxford University Press; 1976.